• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    Alkermes plc (ALKS)

    -NasdaqGS
    37.99 Up 0.37(0.98%) May 5, 4:00PM EDT
    Prev Close:37.62
    Open:37.63
    Bid:28.00 x 100
    Ask:39.70 x 600
    1y Target Est:44.40
    Beta:2.01688
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:37.11 - 38.43
    52wk Range:27.14 - 80.71
    Volume:824,480
    Avg Vol (3m):1,579,260
    Market Cap:5.74B
    P/E (ttm):N/A
    EPS (ttm):-1.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 0.98%5.74B
    LLYUp 0.53%80.02B
    GSKUp 0.17%102.66B
    ABTUp 1.05%56.58B

    Key Statistics

    Forward P/E (1 yr):165.17
    P/S (ttm):9.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.30
    Quarterly EPS Est (Jun-16) :-0.10
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):5.66

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback